3653 results for «302»

Filter By

3653 results

Early outcomes and predictors of success in LATAM TAVI experiences

12 Sep 2025 – From PCR Rio Valves 2025

Explore early outcomes and predictors of success from Latin America's evolving experience with Transcatheter Aortic Valve Implantation (TAVI). This session covers innovative approaches such as transfemoral access intravascular lithotripsy compared to angioplasty, conduction disturbances with self-expandable TAVI devices, and insights from regional centers treating severe aortic...

Out-of-the-box TAVI: when anatomy pushes innovation

12 Sep 2025 – From PCR Rio Valves 2025

Witness innovative TAVI applications pushing procedural boundaries in challenging anatomical scenarios. This session reviews cases including bicuspid valves with septal aneurysm, non-calcific aortic regurgitation with complex aortas, decades-old valve treatments, and novel access strategies in severe peripheral artery disease.

Tricuspid TEER intraprocedural guidance

12 Sep 2025 – From PCR Rio Valves 2025

Master the intraprocedural guidance essential for successful Tricuspid Transcatheter Edge-to-Edge Repair (TEER). This session provides comprehensive insights into pre-procedural analysis, gap measurement techniques, and step-by-step intraprocedural monitoring with expert tips and tricks.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

12 Sep 2025 – From PCR Rio Valves 2025

Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

Extreme TAVI: bicuspid valves, emergency TAVI, dissections and more

12 Sep 2025 – From PCR Rio Valves 2025

Explore extreme and complex TAVI cases that push procedural limits, including urgent interventions, bicuspid valve sizing, valve-in-valve strategies, and rare complications such as type A dissection and late coronary occlusion. This session shares valuable clinical experiences and lessons from challenging scenarios.

Tricuspid valve - Present and future perspectives: a critical appraisal

12 Sep 2025 – From PCR Rio Valves 2025

Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...

Structural heart: demanding anatomies, difficult situations and unusual strategies

12 Sep 2025 – From PCR Rio Valves 2025

Navigate complex structural heart interventions through this session focusing on challenging anatomies and innovative procedural strategies. Topics include orthotopic tricuspid valve replacement amidst anatomical and physiological complexities, percutaneous closure of Valsalva sinus fistula, extreme TAVI approaches for pure aortic regurgitation, management of mitral paravalvular leaks with...

Advanced TAVI: techniques, timing, and problem-solving

12 Sep 2025 – From PCR Rio Valves 2025

Advance your knowledge in TAVI with this session addressing sophisticated techniques, procedural timing, and problem-solving in complex cases. Explore TAVI applications in rare quadricuspid valve anatomy with pure aortic insufficiency, strategic decision-making between TAVI and PCI, and innovative solutions for managing aortic stenosis in patients with...

Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial

16 Nov 2024

Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
ENBALV

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

Transcatheter edge-to-edge repair of functional mitral regurgitation in heart failure: Final five-year results from the COAPT Trial

06 Mar 2023

Alex Sticchi & Jonathan Curio provide their take on the clinical trial presented by Gregg W. Stone at the American College of Cardiology Scientific Sessions (ACC.23/WCC).

Jonathan Curio

Author

Jonathan Curio
Alessandro Sticchi

Author

Alessandro Sticchi
Transcatheter edge-to-edge repair of functional mitral regurgitation in heart failure: Final five-year results from the COAPT Trial

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?